- IN₹181.36bn
- IN₹202.94bn
- IN₹31.29bn
India's Lupin, Eris Lifesciences gain on insulin market share prospects
Brief: Eris Lifesciences Interim Dividend Of 7.35 Rupees Per Share
India's Eris Lifesciences falls on Q3 profit drop
Brief: Eris Lifesciences Dec-Quarter Consol Net Profit 836.3 Mln Rupees
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 915.9 Mln Rupees
Brief: Eris Lifesciences Acquires 100% Stake In Eris Pharmaceuticals
India pharma rally to sustain on higher earnings, says Macquarie
India pharma rally to sustain on higher earnings, says Macquarie
India's Biocon posts Q1 profit rise on sale of branded formulations business
India New Issue-Eris Lifesciences accepts bids for bond issue, bankers say
India New Issue-Eris Lifesciences to issue STRPP bonds, bankers say
India New Issue-Eris Lifesciences to issue 3-year bonds, bankers say
Brief: Eris Lifesciences March-Quarter Consol Net Profit Rises
India's Biocon falls; Kotak says Eris deal valuation below expectations
Brief: Eris Lifesciences To Acquire Branded Formulations Businesses Of Biocon Biologics Pertaining To Indian Territory
India's Biocon to sell branded formulations business to Eris Lifesciences for $150 mln (updated)
India's Biocon climbs on unit's deal for branded formulations business
India's Biocon unit approves transfer of branded formulations biz to Eris Lifesciences
Brief: Biocon- Biocon Biologics Enters Long-Term Commercial Collaboration With Eris Lifesciences